Kelly M. Brady

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Thomas J. DesRosier, Attorney-in-Fact for Kelly M. Brady
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kelly M. Brady:

Company Role Class Num Shares Value Price $ Report Date Ownership
Seres Therapeutics, Inc. Chief Operating Officer, EVP Common Stock 8,441 $69,385 $8.22 02 Mar 2026 Direct
Seres Therapeutics, Inc. Chief Operating Officer, EVP Stock Option (right to buy) 56,250 04 Mar 2026 Direct

Insider Reports Filed by Kelly M. Brady

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MCRB Seres Therapeutics, Inc. 04 Mar 2026 1 $0 4 Chief Operating Officer, EVP 11 Mar 2026, 18:39
MCRB Seres Therapeutics, Inc. 02 Mar 2026 0 $0 3 EVP and Chief Operating Officer Exhibit 24 - Power of Attorney. 11 Mar 2026, 18:30